Jasmina Esterlechner
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Potency assay to predict the anti-inflammatory capacity of a cell therapy product for macrophage-driven diseases: overcoming the challenges of assay development and validation.
Journal: Cytotherapy
Published: September 13, 2023
Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers.
Journal: Stem cell research & therapy
Published: March 31, 2022
Allogeneic ABCB5+ mesenchymal stem cells for treatment-refractory chronic venous ulcers: a phase I/IIa clinical trial.
Journal: JID innovations : skin science from molecules to population health
Published: December 06, 2021
Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa.
Journal: JCI insight
Published: June 01, 2021
Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency.
Journal: Stem cell research & therapy
Published: October 06, 2020
Process data of allogeneic ex vivo-expanded ABCB5+ mesenchymal stromal cells for human use: off-the-shelf GMP-manufactured donor-independent ATMP.
Journal: Stem cell research & therapy
Published: July 22, 2020
In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials.
Journal: Cytotherapy
Published: November 23, 2018
Detection of ABCB5 tumour antigen-specific CD8+ T cells in melanoma patients and implications for immunotherapy.
Journal: Clinical and experimental immunology
Published: September 07, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026